Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atrial fibrillation
MedTech
Boston Scientific expands Farapulse afib reach with new approval
In its first year on the market, Farapulse brought in more than $1 billion in revenue. Now, Boston Scientific aims to reach the full afib population.
Conor Hale
Jul 7, 2025 11:58am
Kardium raises $250M as its afib system undergoes FDA review
Jul 2, 2025 11:00am
Next-gen pulsed field ablation comes to the fore at HRS
Apr 27, 2025 1:15pm
Abbott secures European approval for Volt pulsed field ablation
Mar 27, 2025 3:45pm
J&J MedTech restarts Varipulse's US rollout after stroke reports
Feb 18, 2025 11:00am
Volta Medical's afib AI shows gains in cardiac ablation study
Feb 14, 2025 1:00pm
